The two companies will provide Houston-area customers with tech-enabled, primary care clinics in five convenient, neighborhood Walgreens locations.
The Cupertino-based company has a few key advantages over its technology rivals, including privacy and the huge base of iPhone and Apple Watch users.
The VSee telehealth and telemedicine solution for the Vuzix M300XL and Vuzix Blade Smart Glasses is expected to be commercially available during Q2 2019.
Among the working group members are companies such as AT&T, Doctor on Demand, Fitbit, Google, IBM, Osso VR, Philips, Samsung, Validic and Verizon.
The two companies aim to digitally engage their combined base of more than 5 million customers and reward them to get active and stay healthy.
The market is seemingly slowing down, but both companies see other reasons to be optimistic about digital health investment.
The goal of the challenge is to unleash innovative solutions as CMS continues to move the healthcare system towards value.
Factors driving this growth include growing telecommunications networks, increase in the number of smartphone users, and integration of healthcare and IT.
The AI-powered, voice-enabled tool integrates vital information into patients' electronic health records to maximize clinician time with patients.
The market is expected to reach 279 million units by the end of 2023 with a compound annual growth rate (CAGR) of 8.9%.